Techniques in Coloproctology is an esteemed, peer-reviewed journal hosted by SPRINGER-VERLAG ITALIA SRL, dedicated to advancing the fields of gastroenterology and surgery with a specific focus on innovative techniques and clinical practices in coloproctology. Since its inception in 1998, the journal has been instrumental in fostering knowledge and research dissemination, exemplified by its current recognition in the 2023 quartiles as Q2 in Gastroenterology and Q1 in Surgery, reflecting its impact and relevance within the medical community. With a notable Scopus ranking of #73/551 in Medicine - Surgery and #53/167 in Medicine - Gastroenterology, it serves as a vital resource for practitioners, researchers, and students alike. Although it is not an open-access journal, the journal provides a unique platform for interdisciplinary collaboration and the sharing of cutting-edge findings, pivotal to the ongoing evolution of surgical techniques. As it continues to publish high-quality research through 2024 and beyond, the journal remains at the forefront of improving outcomes in coloproctological practices.

Seminars in Colon and Rectal Surgery is a peer-reviewed journal published by W B Saunders Co-Elsevier Inc, focused on the dynamic fields of gastroenterology and surgical practices related to colon and rectal health. Established in 1996, the journal has evolved to serve as a crucial platform for disseminating innovative research, clinical findings, and thorough reviews relevant to colorectal surgery. It holds an impact factor that reflects its commitment to advancing knowledge in the field, currently ranking in Q4 in Gastroenterology and Q3 in Surgery as of 2023. Researchers and practitioners alike benefit from the latest insights, addressing pivotal topics, treatment paradigms, and surgical techniques that shape modern surgical practices. With a continued focus on enhancing the quality of care in gastrointestinal health, Seminars in Colon and Rectal Surgery plays an essential role in fostering academic dialogue and clinical expertise, making it an invaluable resource for students, professionals, and researchers passionate about advancing the field.

DIGESTION is a prestigious journal dedicated to advancing the field of gastroenterology, published by KARGER, a renowned publisher based in Switzerland. With a rich history dating back to 1896, this journal has continuously evolved and serves as a vital platform for researchers, professionals, and students alike. DIGESTION is recognized for its scholarly contributions, holding an impressive rank of 23 out of 167 in the Scopus database, placing it within the top 14% of gastroenterology journals, as evidenced by its Q2 classification. The journal's commitment to high-quality research is reflected in its wide-ranging scope, addressing various aspects of digestive health, clinical practices, and innovative therapies. Though not an open-access journal, it provides comprehensive access options that ensure the dissemination of crucial research findings to the global community. As we move towards 2024, DIGESTION continues to facilitate dialogue and insights in gastroenterological research, making it an indispensable resource for those in the field.

DIGESTIVE AND LIVER DISEASE is a prominent journal published by Elsevier Science Inc, dedicated to advancing the field of gastroenterology and hepatology. With an ISSN of 1590-8658 and an E-ISSN of 1878-3562, this journal has established itself as a significant resource within the academic community, especially considering its Q2 ranking in both gastroenterology and hepatology categories as of 2023. Spanning from 2000 to 2024, the journal presents a diverse array of peer-reviewed articles, clinical studies, and review papers that explore the latest advancements and research findings in digestive and liver diseases. The journal's robust impact, reflected in its Scopus rankings—40th out of 167 in gastroenterology and 28th out of 82 in hepatology—highlights its critical role in shaping practices and understanding in these vital areas of medicine. With open access options available, DIGESTIVE AND LIVER DISEASE aims to make high-quality research accessible to a wider audience, thereby encouraging collaboration and innovation. Researchers, healthcare professionals, and students alike will find valuable insights into the complex mechanisms, diagnostics, and therapeutic strategies pertinent to digestive and liver health.

Korean Journal of Gastroenterology (ISSN: 1598-9992, E-ISSN: 2233-6869), published by the Korean Society of Gastroenterology, has been a premier outlet for research and advancements in the field of gastroenterology since its inception in 1968. This open-access journal, based in South Korea, fosters a global dialogue on gastrointestinal health, embracing contributions from a diverse array of disciplines within medicine. It is currently ranked in the Q4 quartile for miscellaneous medicine and holds a Scopus rank of #323 out of 636 in general medicine, reflecting its commitment to publishing impactful research despite its relatively recent establishment in high-impact metrics. With a continuous publication timeline extending through to 2024, the journal aims to enhance understanding of gastrointestinal disorders and promote innovative treatments, making it an essential resource for researchers, clinicians, and students alike who seek to stay abreast of the latest developments and clinical applications in gastroenterology.

International Journal of Colorectal Disease is a prestigious peer-reviewed journal published by Springer that focuses on the evolving landscape of colorectal diseases. Established in 1986, this journal has served as a vital platform for researchers, healthcare professionals, and students to explore groundbreaking research, innovative treatment methodologies, and the latest advancements in gastroenterology. With an impressive impact factor and ranked in the Q2 category of gastroenterology by Scopus, it holds a prominent position in the academic community, currently occupying the 59th rank among 167 journals in the field, corresponding to the 64th percentile. Although it does not offer open access, the journal remains invaluable for those seeking in-depth analysis and comprehensive insights into colorectal health issues. As it continues through its convergence years until 2024, the International Journal of Colorectal Disease invites contributions that aim to bridge the gap between research and clinical practice, fostering a deeper understanding of colorectal disorders and enhancing patient care.

INFLAMMATORY BOWEL DISEASES is a premier journal published by Oxford University Press, Inc., dedicated to advancing research within the fields of gastroenterology and immunology. With an impressive impact factor reflecting its status as a Q1 category journal in both gastroenterology and immunology and allergy, it ranks 17th out of 167 in gastroenterology and 53rd out of 233 in immunology, underscoring its influence and authority within the scientific community. Since its inception in 1995 and continuing through to 2024, the journal has become an essential resource for researchers, healthcare professionals, and students, serving as a platform for the latest findings in the diagnosis, treatment, and management of inflammatory bowel diseases. While the journal operates under a subscription-based model, it is recognized for its rigorous peer-review process and commitment to publishing high-caliber, impactful studies that contribute significantly to understanding and treating these complex conditions.

DIGESTIVE SURGERY, published by KARGER in Switzerland, is a leading journal at the forefront of its field, focusing on innovative surgical techniques and advancements in gastrointestinal surgery. With an ISSN of 0253-4886 and an E-ISSN of 1421-9883, this esteemed journal has been disseminating critical research since its inception in 1984, and is set to continue shaping the discipline until 2024. DIGESTIVE SURGERY holds an impressive impact factor, reflected in its 2023 ranking, positioned in the Q2 quartile for Gastroenterology and Q1 for Surgery. It is recognized within the Scopus database as #93 out of 551 in Surgery and #61 out of 167 in Gastroenterology, placing it in the top percentiles of both fields. While the journal is not open access, it remains a pivotal resource for practitioners, researchers, and students seeking to deepen their understanding of surgical practices and innovations that enhance patient care.

Translational Gastroenterology and Hepatology, published by AME Publishing Company, stands as a pivotal platform for advancing the understanding and treatment of gastrointestinal and liver diseases. With its focus on translational research, this journal aims to bridge the gap between laboratory discoveries and clinical applications, thus fostering improvements in patient care. Although specific metrics like H-Index and Scopus ranks are currently unavailable, the journal is committed to maintaining high standards of scholarly communication and excellence. As an open-access publication, it ensures that valuable findings are readily accessible to a global audience, promoting collaboration and innovation among researchers, clinicians, and healthcare professionals invested in gastroenterology and hepatology. The journal's dedication to disseminating groundbreaking research makes it an essential resource for those seeking to stay at the forefront of these ever-evolving fields.

Hepatobiliary & Pancreatic Diseases International, an esteemed journal published by Elsevier, stands as a vital resource within the field of gastroenterology and hepatology. Established in 2002, this journal has developed a significant reputation, currently ranked in the second quartile (Q2) in both categories as of 2023, showcasing its commitment to high-quality research and clinical studies. Based in Singapore, Hepatobiliary & Pancreatic Diseases International serves as an essential platform for researchers, clinicians, and healthcare professionals to share innovative findings, therapeutic approaches, and advancements in the understanding of hepatobiliary and pancreatic diseases. Although the journal does not currently offer Open Access, its rigorous peer-review process ensures that published articles maintain the highest scientific standards, fostering knowledge dissemination among the global research community. With a convergence period extending to 2024, this journal continues to play a pivotal role in enhancing the understanding and treatment of complex gastrointestinal conditions, making it a must-read for anyone engaged in this dynamic field.